MLL-Rearranged Leukemias: Insights From Gene Expression Profiling

Seminars in Hematology

Volumn 40, Issue 4, 2003, Pages 268-273

  Armstrong, Scott A ^b   Golub, Todd R ^b   Korsmeyer, Stanley J ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BONE MARROW CELL; CANCER RESISTANCE; CARCINOGENESIS; CHROMOSOME 11Q; CHROMOSOME TRANSLOCATION; DISEASE CLASSIFICATION; DRUG TARGETING; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; HUMAN; LEUKEMIA; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0142062911     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(03)00196-3     Document Type: Article

References (43)

1. Allander SV, Nupponen NN, Ringner M, et al: Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile. Cancer Res 61:8624-8628, 2001
2. Armstrong SA, Hsieh JJ, Korsmeyer SJ: Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias. Curr Opin Hematol 9:339-344, 2002
3. Armstrong SA, Kung AL, Mabon ME, et al: Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification. Cancer Cell 3:173-183, 2003
4. Armstrong SA, Staunton JE, Silverman LB, et al: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30:41-47, 2002
5. Ayton PM, Cleary ML: Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20:5695-5707, 2001
6. Biondi A, Cimino G, Pieters R, et al: Biological and therapeutic aspects of infant leukemia. Blood 96:24-33, 2000
7. Borrow J, Shearman AM, Stanton VP Jr, et al: The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet 12:159-167, 1996
8. Buske C, Humphries RK: Homeobox genes in leukemogenesis. Int J Hematol 71:301-308, 2000
9. Chen CS, Sorensen PH, Domer PH, et al: Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 81:2386-2393, 1993
10. Cumano A, Paige CJ, Iscove NN, et al: Bipotential precursors of B cells and macrophages in murine fetal liver. Nature 356:612-615, 1992
11. + mouse bone marrow progenitor cells restricted to macrophage differentiation that coexpress early B cell-associated genes. Exp Hematol 27:1646-1654, 1999
12. Debernardi S, Lillington DM, Chaplin T, et al: Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer 37:149-158, 2003
13. Demetri GD, von Mehren M, Blanke CD, et al: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472-480, 2002
14. DiMartino JF, Miller T, Ayton PM, et al: A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL. Blood 96:3887-3893, 2000
15. Domer PH, Fakharzadeh SS, Chen CS, et al: Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci USA 90:7884-7888, 1993
16. Druker BJ, Talpaz M, Resta DJ, et al: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031-1037, 2001
17. Felix CA, Hosler MR, Winick NJ, et al: ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children. Blood 85:3250-3256, 1995
18. Ferrando AA, Armstrong SA, Neuberg DS, et al: Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: Dominance of HOX dysregulation. Blood 102:262-268, 2003
19. Ferrando AA, Neuberg DS, Staunton J, et al: Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1:75-87, 2002
20. Gorre ME, Mohammed M, Ellwood K, et al: Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293:876-880, 2001
21. Greaves MF, Chan LC, Furley AJ, et al: Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 67:1-11, 1986
22. Gu Y, Nakamura T, Alder H, et al: The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71:701-708, 1992
23. Hess JL, Yu BD, Li B, et al: Defects in yolk sac hematopoiesis in Mll-null embryos. Blood 90:1799-1806, 1997
24. McCulloch EA: Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982). Blood 62:1-13, 1983
25. Miettinen M, Majidi M, Lasota J: Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): A review. Eur J Cancer 38:S39-51, 2002 (suppl 5)
26. Milne TA, Briggs SD, Brock HW, et al: MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell 10:1107-1117, 2002
27. Montecino-Rodriguez E, Leathers H, Dorshkind K: Bipotential B-macrophage progenitors are present in adult bone marrow. Nat Immunol 2:83-88, 2001
28. Nakamura T, Largaespada DA, Lee MP, et al: Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet 12:154-158, 1996
29. Nakamura T, Mori T, Tada S, et al: ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 10:1119-1128, 2002
30. Owens BM, Hawley RG: HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells 20:364-379, 2002
31. Rowley JD: The critical role of chromosome translocations in human leukemias. Annu Rev Genet 32:495-519, 1998
32. Rubnitz JE, Raimondi SC, Tong X, et al: Favorable impact of the t(9;11) in childhood acute myeloid leukemia. J Clin Oncol 20:2302-2309, 2002
33. Silverman LB, McLean TW, Gelber RD, et al: Intensified therapy for infants with acute lymphoblastic leukemia: Results from the Dana-Farber Cancer Institute Consortium. Cancer 80:2285-2295, 1997
34. So CW, Karsunky H, Passegue E, et al: MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice. Cancer Cell 3:161-171, 2003
35. Thorsteinsdottir U, Mamo A, Kroon E, et al: Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99:121-129, 2002
36. Thorsteinsdottir U, Sauvageau G, Humphries RK: Enhanced in vivo regenerative potential of HOXB4-transduced hematopoietic stem cells with regulation of their pool size. Blood 94:2605-2612, 1999
37. Tkachuk DC, Kohler S, Cleary ML: Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71:691-700, 1992
38. Yamamoto Y, Kiyoi H, Nakano Y, et al: Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 97:2434-2439, 2001
39. Yeoh EJ, Ross ME, Shurtleff SA, et al: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1:133-143, 2002
40. Yu BD, Hanson RD, Hess JL, et al: MLL, a mammalian trithorax-group gene, functions as a, transcriptional maintenance factor in morphogenesis. Proc Natl Acad Sci USA 95:10632-10636, 1998
41. Yu BD, Hess JL, Horning SE, et al: Altered Hox expression and segmental identity in Mll-mutant mice. Nature 378:505-508, 1995
42. Zeisig BB, Garcia-Cuellar MP, Winkler TH, et al: The oncoprotein MLL-ENL disturbs hematopoietic lineage determination and transforms a biphenotypic lymphoid/myeloid cell. Oncogene 22:1629-1637, 2003
43. Ziemin-van der Poel S, McCabe NR, Gill HJ, et al: Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88:10735-10739, 1991